WEBINAR - Archives

The Clinical Implications of Gastrointestinal Biofilm with Stephen F. Olmsted, MD


Take a deeper look at biofilms made by beneficial microbes and how they contribute to normal gut and immune function with Dr. Stephen Olmstead.

This presentation will address the nature of microbial biofilms and take a deeper look at the advantages of life within biofilms associated with Helicobacter pylori infections and candidiasis sensitivity syndrome. Dr Olmstead will reveal how biofilms made by beneficial microbes contribute to normal gut and immune function while those produced by pathogens contribute to disease. Viewers can expect to achieve greater understanding of the nature and properties of biofilms, understand the contribution of pathogenic biofilm to chronic and recurrent infections, and learn how to disrupt pathogenic biofilm using antibiofilm enzymes.

Stephen F. Olmstead, MD, is Chief Science Officer at ProThera, Inc. where he directs clinical trials of ProThera® and Klaire Labs™ nutraceutical products. He received his MD from the University of New Mexico in 1979 and completed his Internal Medicine residency at Harvard Medical School, Massachusetts General Hospital in 1982 and fellowship in Cardiovascular Diseases at the University of Washington in 1987. His current research focuses on the use of enzymes and chelating agents to disrupt pathogenic GI biofilm and pre- and probiotics to restore gut microbial balance.

Hawthorn University students and graduates are also encouraged to join in on post-webinar discussions on the Hawthorn Forums. On your forum, just navigate to General Questions and Postings > Teleclasses and Webinars to post or join in on any discussions.

Click Here for a PDF copy of the slide presentation used in this webinar.